← 產業報告目錄
AI/ML and Computational Tools in RNA Research and Therapeutics Market Size, Share & Trends Analysis Distribution by Technologies and Processes (RNA Design and Sequence Optimization, RNA Delivery Systems, RNA Sequencing and Data Analysis, Target Identification and Validation, Preclinical and Clinical Development Tools, Hardware and Infrastructure Support), Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Other Therapeutics), End-User (Pharmaceutical and Biotech Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Healthcare Providers (Emerging)) and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-01-14頁數 180報告編號 INSIGHTACE-67d88965b0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the AI/ML and Computational Tools in RNA Research and Therapeutics Market globally will accelerate at a 26.8% CAGR during 2025–2034.
AI/ML and Computational Tools in RNA Research and Therapeutics covers transforming rna research and therapeutics by enabling a deeper understanding of rna biology and expediting drug discov. Rapid advancements and evolving end-user preferences are reshaping how technology and communications entities approach this space.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI/ML and Computational Tools in RNA Research and Therapeutics Market Snapshot
Chapter 4. Global AI/ML and Computational Tools in RNA Research and Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on AI/ML and Computational Tools in RNA Research and Therapeutics Market Industry Trends
4.10. Global AI/ML and Computational Tools in RNA Research and Therapeutics Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI/ML and Computational Tools in RNA Research and Therapeutics Market Segmentation 1: By Technologies and Processes, Estimates & Trend Analysis
5.1. Market Share by Technologies and Processes, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technologies and Processes:
5.2.1. RNA Design and Sequence Optimization
5.2.2. RNA Delivery Systems
5.2.3. RNA Sequencing and Data Analysis
5.2.4. Target Identification and Validation
5.2.5. Preclinical and Clinical Development Tools
5.2.6. Hardware and Infrastructure Support
Chapter 6. AI/ML and Computational Tools in RNA Research and Therapeutics Market Segmentation 2: By Product, Estimates & Trend Analysis
6.1. Market Share by Product, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the
following Product:
6.2.1. Vaccines
6.2.2. Drugs
Chapter 7. AI/ML and Computational Tools in RNA Research and Therapeutics Market Segmentation 3: By Type, Estimates & Trend Analysis
7.1. Market Share by Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type:
7.2.1. mRNA Therapeutics
7.2.2. RNA Interference (RNAi) Therapeutics
7.2.3. Antisense Oligonucleotide (ASO) Therapeutics
7.2.4. Other Therapeutics
Chapter 8. AI/ML and Computational Tools in RNA Research and Therapeutics Market Segmentation 3: By End-user, Estimates & Trend Analysis
8.1. Market Share by End-user, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
8.2.1. Pharmaceutical and Biotech Companies
8.2.2. Academic and Research Institutions
8.2.3. Contract Research Organizations (CROs)
8.2.4. Healthcare Providers (Emerging)
Chapter 9. AI/ML and Computational Tools in RNA Research and Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
9.1. Global AI/ML and Computational Tools in RNA Research and Therapeutics Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technologies and Processes, 2021-2034
9.2.3. North America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.4. North America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.5. North America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.3. Europe
9.3.1. Europe AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technologies and Processes, 2021-2034
9.3.3. Europe AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.4. Europe AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.5. Europe AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technologies and Processes, 2021-2034
9.4.3. Asia Pacific AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.4. Asia Pacific AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.4.5. Asia Pacific AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.5. Latin America
9.5.1. Latin America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technologies and Processes, 2021-2034
9.5.3. Latin America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.4. Latin America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-20349.5.5. Latin America AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Technologies and Processes, 2021-2034
9.6.3. Middle East & Africa AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.6.4. Middle East & Africa AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.6.5. Middle East & Africa AI/ML and Computational Tools in RNA Research and Therapeutics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Deep Genomics
10.2.1.1. Business Overview
10.2.1.2. Key Technologies and Processes/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Insilico Medicine
10.2.3. Atomwise
10.2.4. Schrödinger
10.2.5. Generate Biomedicines
10.2.6. e-therapeutics
10.2.7. NVIDIA
10.2.8. Illumina
10.2.9. Relation Therapeutics
10.2.10. BenevolentAI
10.2.11. Fluence Technologies
10.2.12. Satija Lab
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們